#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Limited dCTP Availability Accounts for Mitochondrial DNA Depletion in Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)


Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a severe human disease caused by mutations in TYMP, the gene encoding thymidine phosphorylase (TP). It belongs to a broader group of disorders characterized by a pronounced reduction in mitochondrial DNA (mtDNA) copy number in one or more tissues. In most cases, these disorders are caused by mutations in genes involved in deoxyribonucleoside triphosphate (dNTP) metabolism. It is generally accepted that imbalances in mitochondrial dNTP pools resulting from these mutations interfere with mtDNA replication. Nonetheless, the precise mechanistic details of this effect, in particular, how an excess of a given dNTP (e.g., imbalanced dTTP excess observed in TP deficiency) might lead to mtDNA depletion, remain largely unclear. Using an in organello replication experimental model with isolated murine liver mitochondria, we observed that overloads of dATP, dGTP, or dCTP did not reduce the mtDNA replication rate. In contrast, an excess of dTTP decreased mtDNA synthesis, but this effect was due to secondary dCTP depletion rather than to the dTTP excess in itself. This was confirmed in human cultured cells, demonstrating that our conclusions do not depend on the experimental model. Our results demonstrate that the mtDNA replication rate is unaffected by an excess of any of the 4 separate dNTPs and is limited by the availability of the dNTP present at the lowest concentration. Therefore, the availability of dNTP is the key factor that leads to mtDNA depletion rather than dNTP imbalances. These results provide the first test of the mechanism that accounts for mtDNA depletion in MNGIE and provide evidence that limited dNTP availability is the common cause of mtDNA depletion due to impaired anabolic or catabolic dNTP pathways. Thus, therapy approaches focusing on restoring the deficient substrates should be explored.


Vyšlo v časopise: Limited dCTP Availability Accounts for Mitochondrial DNA Depletion in Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE). PLoS Genet 7(3): e32767. doi:10.1371/journal.pgen.1002035
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002035

Souhrn

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a severe human disease caused by mutations in TYMP, the gene encoding thymidine phosphorylase (TP). It belongs to a broader group of disorders characterized by a pronounced reduction in mitochondrial DNA (mtDNA) copy number in one or more tissues. In most cases, these disorders are caused by mutations in genes involved in deoxyribonucleoside triphosphate (dNTP) metabolism. It is generally accepted that imbalances in mitochondrial dNTP pools resulting from these mutations interfere with mtDNA replication. Nonetheless, the precise mechanistic details of this effect, in particular, how an excess of a given dNTP (e.g., imbalanced dTTP excess observed in TP deficiency) might lead to mtDNA depletion, remain largely unclear. Using an in organello replication experimental model with isolated murine liver mitochondria, we observed that overloads of dATP, dGTP, or dCTP did not reduce the mtDNA replication rate. In contrast, an excess of dTTP decreased mtDNA synthesis, but this effect was due to secondary dCTP depletion rather than to the dTTP excess in itself. This was confirmed in human cultured cells, demonstrating that our conclusions do not depend on the experimental model. Our results demonstrate that the mtDNA replication rate is unaffected by an excess of any of the 4 separate dNTPs and is limited by the availability of the dNTP present at the lowest concentration. Therefore, the availability of dNTP is the key factor that leads to mtDNA depletion rather than dNTP imbalances. These results provide the first test of the mechanism that accounts for mtDNA depletion in MNGIE and provide evidence that limited dNTP availability is the common cause of mtDNA depletion due to impaired anabolic or catabolic dNTP pathways. Thus, therapy approaches focusing on restoring the deficient substrates should be explored.


Zdroje

1. SuomalainenAIsohanniP 2010 Mitochondrial DNA depletion syndromes - Many genes, common mechanisms. Neuromuscul Disord 20 429 437

2. BourdonAMinaiLSerreVJaisJPSarziE 2007 Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 39 776 780

3. MandelHSzargelRLabayVElpelegOSaadaA 2001 The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 29 337 341

4. NishinoISpinazzolaAHiranoM 1999 Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283 689 692

5. SaadaAShaagAMandelHNevoYErikssonS 2001 Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 29 342 344

6. PontarinGFijolekAPizzoPFerraroPRampazzoC 2008 Ribonucleotide reduction is a cytosolic process in mammalian cells independently of DNA damage. Proc Natl Acad Sci U S A 105 17801 17806

7. LopezLCAkmanHOGarcia-CazorlaADoradoBMartiR 2009 Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice. Hum Mol Genet 18 714 722

8. RampazzoCMiazziCFranzolinEPontarinGFerraroP 2010 Regulation by degradation, a cellular defense against deoxyribonucleotide pool imbalances. Mutat Res 703 2 10

9. BjursellGReichardP 1973 Effects of thymidine on deoxyribonucleoside triphosphate pools and deoxyribonucleic acid synthesis in Chinese hamster ovary cells. J Biol Chem 248 3904 3909

10. FerraroPPontarinGCroccoLFabrisSReichardP 2005 Mitochondrial deoxynucleotide pools in quiescent fibroblasts: a possible model for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). J Biol Chem 280 24472 24480

11. PontarinGFerraroPValentinoMLHiranoMReichardP 2006 Mitochondrial DNA depletion and thymidine phosphate pool dynamics in a cellular model of mitochondrial neurogastrointestinal encephalomyopathy. J Biol Chem 281 22720 22728

12. SongSWheelerLJMathewsCK 2003 Deoxyribonucleotide pool imbalance stimulates deletions in HeLa cell mitochondrial DNA. J Biol Chem 278 43893 43896

13. EnriquezJARamosJPerez-MartosALopez-PerezMJMontoyaJ 1994 Highly efficient DNA synthesis in isolated mitochondria from rat liver. Nucleic Acids Res 22 1861 1865

14. PfaffEKlingenbergM 1968 Adenine nucleotide translocation of mitochondria. 1. Specificity and control. Eur J Biochem 6 66 79

15. DueeEDVignaisPV 1969 Kinetics and specificity of the adenine nucleotide translocation in rat liver mitochondria. J Biol Chem 244 3920 3931

16. WangLSaadaAErikssonS 2003 Kinetic properties of mutant human thymidine kinase 2 suggest a mechanism for mitochondrial DNA depletion myopathy. J Biol Chem 278 6963 6968

17. WangLErikssonS 2000 Cloning and characterization of full-length mouse thymidine kinase 2: the N-terminal sequence directs import of the precursor protein into mitochondria. Biochem J 351 Pt 2 469 476

18. YlikallioEPageJLXuXLampinenMBeplerG 2010 Ribonucleotide reductase is not limiting for mitochondrial DNA copy number in mice. Nucleic Acids Res 38 8208 8218

19. NishigakiYMartiRCopelandWCHiranoM 2003 Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J Clin Invest 111 1913 1921

20. NishigakiYMartiRHiranoM 2004 ND5 is a hot-spot for multiple atypical mitochondrial DNA deletions in mitochondrial neurogastrointestinal encephalomyopathy. Hum Mol Genet 13 91 101

21. BridgesEGJiangZChengYC 1999 Characterization of a dCTP transport activity reconstituted from human mitochondria. J Biol Chem 274 4620 4625

22. BulstSAbichtAHolinski-FederEMuller-ZiermannSKoehlerU 2009 In vitro supplementation with dAMP/dGMP leads to partial restoration of mtDNA levels in mitochondrial depletion syndromes. Hum Mol Genet 18 1590 1599

23. TaanmanJWMuddleJRMuntauAC 2003 Mitochondrial DNA depletion can be prevented by dGMP and dAMP supplementation in a resting culture of deoxyguanosine kinase-deficient fibroblasts. Hum Mol Genet 12 1839 1845

24. HiranoMMartiRCasaliCTadesseSUldrickT 2006 Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 67 1458 1460

25. BeumerJHEisemanJLGilbertJAHolleranJLYellow-DukeAE 2011 Plasma pharmacokinetics and oral bioavailability of the 3,4,5,6-tetrahydrouridine (THU) prodrug, triacetyl-THU (taTHU), in mice. Cancer Chemother Pharmacol 67 421 430

26. Fernandez-VizarraELopez-PerezMJEnriquezJA 2002 Isolation of biogenetically competent mitochondria from mammalian tissues and cultured cells. Methods 26 292 297

27. ReyesAYasukawaTHoltIJ 2007 Analysis of replicating mitochondrial DNA by two-dimensional agarose gel electrophoresis. Methods Mol Biol 372 219 232

28. FerraroPFranzolinEPontarinGReichardPBianchiV 2010 Quantitation of cellular deoxynucleoside triphosphates. Nucleic Acids Res 38 e85

29. CrespoMSauledaSEstebanJIJuarezARiberaE 2007 Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients. J Viral Hepat 14 228 238

30. LaiYTseCMUnadkatJD 2004 Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs. J Biol Chem 279 4490 4497

31. LeeEWLaiYZhangHUnadkatJD 2006 Identification of the mitochondrial targeting signal of the human equilibrative nucleoside transporter 1 (hENT1): implications for interspecies differences in mitochondrial toxicity of fialuridine. J Biol Chem 281 16700 16706

32. FerraroPNicolosiLBernardiPReichardPBianchiV 2006 Mitochondrial deoxynucleotide pool sizes in mouse liver and evidence for a transport mechanism for thymidine monophosphate. Proc Natl Acad Sci U S A 103 18586 18591

33. AntesATappinIChungSLimRLuB 2010 Differential regulation of full-length genome and a single-stranded 7S DNA along the cell cycle in human mitochondria. Nucleic Acids Res 38 6466 6476

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2011 Číslo 3
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#